South African-led Study Supports Use of Cepheid Test for Diagnosing TB in Children | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid's Xpert MTB/RIF molecular test can detect pediatric tuberculosis cases more accurately than smear microscopy of sputum samples, according to a study in the early, online version of The Lancet Infectious Diseases today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."